Glioma Mesoscopic Imaging

• Conditions: C71.9; D43.2; Brain, unspecified

• Registration Number: DRKS00005580
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

Patients with suspected glioma (low grade, anaplastic,GBM) prior to stereotactic biopsy - Patients with a known but presumably progressive glioma prior to re-biopsy

Exclusion Criteria

Unability to cosent - Minor - Any contraindication against MRI - Renal Insufficiency (GFR < 30 ml/min x 1.73)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stereotactic biopsy: comparison of histologically proven infiltration and mesoscopic parameters

Secondary Outcome Measures

Name	Time	Method
Tumour progression according to RANO criteria within the 3-monthly follow-up investigations. <br>The time point of progressive disease is individual for each participant.